| Literature DB >> 24739341 |
Stacy M Crim, Martha Iwamoto, Jennifer Y Huang, Patricia M Griffin, Debra Gilliss, Alicia B Cronquist, Matthew Cartter, Melissa Tobin-D'Angelo, David Blythe, Kirk Smith, Sarah Lathrop, Shelley Zansky, Paul R Cieslak, John Dunn, Kristin G Holt, Susan Lance, Robert Tauxe, Olga L Henao.
Abstract
Foodborne disease continues to be an important problem in the United States. Most illnesses are preventable. To evaluate progress toward prevention, the Foodborne Diseases Active Surveillance Network (FoodNet) monitors the incidence of laboratory-confirmed infections caused by nine pathogens transmitted commonly through food in 10 U.S. sites, covering approximately 15% of the U.S. population. This report summarizes preliminary 2013 data and describes trends since 2006. In 2013, a total of 19,056 infections, 4,200 hospitalizations, and 80 deaths were reported. For most infections, incidence was well above national Healthy People 2020 incidence targets and highest among children aged <5 years. Compared with 2010-2012, the estimated incidence of infection in 2013 was lower for Salmonella, higher for Vibrio, and unchanged overall.† Since 2006-2008, the overall incidence has not changed significantly. More needs to be done. Reducing these infections requires actions targeted to sources and pathogens, such as continued use of Salmonella poultry performance standards and actions mandated by the Food Safety Modernization Act (FSMA). FoodNet provides federal and state public health and regulatory agencies as well as the food industry with important information needed to determine if regulations, guidelines, and safety practices applied across the farm-to-table continuum are working.Entities:
Mesh:
Year: 2014 PMID: 24739341 PMCID: PMC5779392
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
Number of cases of culture-confirmed bacterial and laboratory-confirmed parasitic infection, hospitalizations, and deaths, by pathogen — Foodborne Diseases Active Surveillance Network, United States, 2013*
| Cases | Hospitalizations | Deaths | |||||
|---|---|---|---|---|---|---|---|
|
|
|
| |||||
| Pathogen | No. | Incidence | Objective | No. | (%) | No. | (%) |
|
| |||||||
| | 6,621 | 13.82 | 8.5 | 1,010 | (15) | 12 | (0.2) |
| | 123 | 0.26 | 0.2 | 112 | (91) | 24 | (19.5) |
| | 7,277 | 15.19 | 11.4 | 2,003 | (28) | 27 | (0.4) |
| | 2,309 | 4.82 | N/A | 450 | (19) | 3 | (0.1) |
| STEC O157 | 552 | 1.15 | 0.6 | 210 | (38) | 2 | (0.4) |
| STEC non-O157 | 561 | 1.17 | N/A | 76 | (14) | 2 | (0.4) |
| | 242 | 0.51 | 0.2 | 55 | (23) | 2 | (0.8) |
| | 171 | 0.36 | 0.3 | 55 | (32) | 4 | (2.3) |
|
| |||||||
| | 1,186 | 2.48 | N/A | 227 | (19) | 4 | (0.3) |
| | 14 | 0.03 | N/A | 2 | (14) | 0 | (0.0) |
|
|
|
|
| ||||
Abbreviations: N/A = not available; STEC = Shiga toxin–producing Escherichia coli.
Data for 2013 are preliminary.
Per 100,000 population.
Healthy People 2020 objective targets for incidence of Campylobacter, Listeria, Salmonella, STEC O157, Vibrio, and Yersinia infections per 100,000 population.
No national health objective exists for these pathogens.
FIGURE 1Estimated percentage change in incidence of culture-confirmed bacterial and laboratory-confirmed parasitic infections in 2013 compared with average annual incidence during 2010–2012, by pathogen — Foodborne Diseases Active Surveillance Network, United States
Abbreviations: CI = confidence interval; STEC = Shiga toxin–producing Escherichia coli.
* No significant change = 95% CI is both above and below the no change line; significant increase = estimate and entire CI are above the no change line; significant decrease = estimate and entire CI are below the no change line.
FIGURE 2Relative rates of culture-confirmed infections with Campylobacter, STEC* O157, Listeria, Salmonella, and Vibrio compared with 2006–2008 rates, by year — Foodborne Diseases Active Surveillance Network, United States, 2006–2013†
* Shiga toxin–producing Escherichia coli.
† The position of each line indicates the relative change in the incidence of that pathogen compared with 2006–2008. The actual incidences of these infections cannot be determined from this figure.